Skip to main content
News Tag: news
The Raptor Trial (NRG-LU007) for Extensive Stage Small Cell Lung Cancer
Read More
A New Trial in Localized High Risk Prostate Cancer (GU009) is Opening Soon!
Read More
Randomized phase III trial of radiation therapy with or without pembrolizumab for women with high intermediate risk mismatch repair deficient (dMMR) endometrioid endometrial cancer (NRG-GY020)
Read More
Genomic Analysis Predicts Survival Benefit of Adjuvant Chemotherapy Following Radiotherapy over Radiotherapy Alone in Low-Grade Gliomas in NRG Oncology Clinical Trial
Read More
Calling all NRG Oncology Investigators! NRG-GY022 is open for ANY cancer patient undergoing carboplatin treatment, any cycle!
Read More
Calling ALL Disease Sites! NRG-GY022 Open for ALL Patients Undergoing Carboplatin Treatment
Read More
Dr. Bauman named Co-Chair of the NCI Cancer Prevention Steering Committee
Read More
NRG Oncology Trial Compares Sentinel Lymph Node Biopsy to Standard Neck Dissection for patients with Early-stage Oral Cavity Cancer
Read More
The NRG Oncology SOROCk Trial Compares Two Surgical Procedures in Women with BRCA1 Mutations to Assess Risk Reduction for Ovarian Cancer
Read More
André Robidoux, MD, long-time researcher with the NSABP and NRG Oncology, dies in Montreal
Read More